About this trial
The aim of this study is to assess the impact of implementing a patient education and preparation protocol for FDG PET (18F-FDG PET) imaging on the quality of imaging results.
18F-FDG (18Fluor-FluoroDesoxyGlucose) PET (Positron Emission Tomography) is indicated for the diagnosis of cardiac inflammation. To detect cardiac inflammation, the myocardium (heart muscle) must be prevented from absorbing glucose from the diet (FDG). To achieve this, patient preparation is essential. Poor preparation can compromise the interpretation of results, causing diagnostic delay.
To answer the research question, the investigators plan to include 138 people with suspected infective endocarditis or cardiac sarcoidosis, in two institutions of the Assistance Publique - Hôpitaux de Paris: Hôpital Européen Georges Pompidou and Hôpital Cochin-Port-Royal, located respectively at 20 rue Leblanc 75015 Paris and 27 rue du Faubourg Saint-Jacques 75014 Paris.
Eligibility criteria
Qualifiers
Presence of a prescription validated by the nuclear medicine department for an 18F-FDG PET scan for the detection of inflammation of cardiac inflammation or infection
Age greater than or equal to 18
Membership of a social security scheme or equivalent
Patients with an e-mail address
Disqualifiers
Pregnancy or breast-feeding
Patients (inpatients or outpatients) already on a diet (including ketogenic)
Patients who do not understand protocol
Patients deprived of liberty by judicial or administrative decision
Trial design
Treatments tested in this trial
- Sending a link to the video
- Compliance questionnaire
- Determination of beta-hydroxybutyrate (BHB) in capillary blood